The role of p38 in irinotecan-induced DNA damage and apoptosis of colon cancer cells

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 741-742, Issue , 2013, Pages 27-34

  Rudolf, E ^a   Kralova, V ^a   Rudolf, K ^a   John, S ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Apoptosis; Colon cancer; DNA damage; Irinotecan; P38

Indexed keywords

IRINOTECAN; MITOGEN ACTIVATED PROTEIN KINASE P38;

APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; AUTOPHAGY; BLOTTING, WESTERN; CAMPTOTHECIN; CASPASES; COLONIC NEOPLASMS; CYTOCHROMES C; DNA DAMAGE; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME-LAPSE IMAGING; TUMOR CELLS, CULTURED;

EID: 84875834010     PISSN: 00275107     EISSN: 09218262     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2013.02.002     Document Type: Article

References (34)

1. Zarubin T., Han J. Activation and signaling of the p38 MAP kinase pathway. Cell. Res. 2005, 15:11-18.
2. Cuenda A., Rousseau S. p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim. Biophys. Acta 2007, 1773:1358-1375.
3. Enslen H., Raingeaud J., Davis R.J. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J. Biol. Chem. 1998, 273:1741-1748.
4. Ashwell J.D. The many paths to p38 mitogen-activated protein kinase activation in the immune system. Nat. Rev. Immunol. 2006, 6:532-540.
5. Shi Y., Gaestel M. In the cellular garden of forking paths: how p38 MAPKs signal for downstream assistance. Biol. Chem. 2002, 383:1519-1536.
6. Phong M.S., Van Horn R.D., Li S., Tucker-Kellogg G., Surana U., Ye X.S. p38 mitogen-activated protein kinase promotes cell survival in response to DNA damage but is not required for the G(2) DNA damage checkpoint in human cancer cells. Mol. Cell. Biol. 2010, 30:3816-3826.
7. Bulavin D.V., Fornace A.J. p38 MAP kinase's emerging role as a tumor suppressor. Adv. Cancer Res. 2004, 92:95-118.
8. Dolado I., Swat A., Ajenjo N., De Vita G., Cuadrado A., Nebreda A.R. p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis. Cancer Cell 2007, 11:191-205.
9. Comes F., Matrone A., Lastella P., Nico B., Susca F.C., Bagnulo R., Ingravallo G., Modica S., Lo Sasso G., Moschetta A., Guanti G., Simone C. A novel cell type-specific role of p38alpha in the control of autophagy and cell death in colorectal cancer cells. Cell Death Differ. 2007, 14:693-702.
10. Pommier Y. Topoisomerase I inhibitors: camptothecins and beyond. Nat. Rev. Cancer 2006, 6:789-802.
11. Gagne J.F., Montminy V., Belanger P., Journault K., Gaucher G., Guillemette C. Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38). Mol. Pharmacol. 2002, 62:608-617.
12. Nakatomi K., Yoshikawa M., Oka M., Ikegami Y., Hayasaka S., Sano K., Shiozawa K., Kawabata S., Soda H., Ishikawa T., Tanabe S., Kohno S. Transport of 7-ethyl-10-hydroxycamptothecin (SN-38) by breast cancer resistance protein ABCG2 in human lung cancer cells. Biochem. Biophys. Res. Commun. 2001, 288:827-832.
13. Li H., Wang P., Sun Q., Ding W.X., Yin X.M., Sobol R.W., Stolz D.B., Yu J., Zhang L. Following cytochrome c release, autophagy is inhibited during chemotherapy-induced apoptosis by caspase 8-mediated cleavage of Beclin 1. Cancer Res. 2011, 71:3625-3634.
14. Laughton C. Quantification of attached cells in microtiter plates based on Coomassie brilliant blue G-250 staining of total cellular protein. Anal. Biochem. 1984, 140:417-423.
15. Simone C. Signal-dependent control of autophagy and cell death in colorectal cancer cell: the role of the p38 pathway. Autophagy 2007, 3:468-471.
16. Sanchez-Prieto R., Rojas J.M., Taya Y., Gutkind J.S. A role for the p38 mitogen-acitvated protein kinase pathway in the transcriptional activation of p53 on genotoxic stress by chemotherapeutic agents. Cancer Res. 2000, 60:2464-2472.
17. Vanhoefer U., Harstrick A., Achterrath W., Cao S., Seeber S., Rustum Y.M. Irinotecan in the treatment of colorectal cancer: clinical overview. J. Clin. Oncol. 2001, 19:1501-1518.
18. Fiorentini G., Rossi S., Dentico P., Bernardeschi P., Calcinai A., Bonechi F., Cantore M., Guadagni S., De Simone M. Irinotecan hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: a phase II clinical study. Tumori 2003, 89:382-384.
19. Ettlinger D.E., Mitterhauser M., Wadsak W., Ostermann E., Farkouh A., Schueller J., Czejka M. In vivo disposition of irinotecan (CPT-11) and its metabolites in combination with the monoclonal antibody cetuximab. Anticancer Res. 2006, 26:1337-1341.
20. Hofmann C., Buttenschoen K., Straeter J., Henne-Bruns D., Kornmann M. Pre-clinical evaluation of the activity of irinotecan as a basis for regional chemotherapy. Anticancer Res. 2005, 25:795-804.
21. Ling X., He X., Apontes P., Cao F., Azrak R.G., Li F. Enhancing effectiveness of the MDR-sensitive compound T138067 using advanced treatment with negative modulators of the drug-resistant protein survivin. Am. J. Transl. Res. 2009, 1:393-405.
22. Chiu S.J., Chao J.I., Lee Y.J., Hsu T.S. Regulation of gamma-H2AX and securin contribute to apoptosis by oxaliplatin via a p38 mitogen-activated protein kinase-dependent pathway in human colorectal cancer cells. Toxicol. Lett. 2008, 179:63-70.
23. Wu C.C., Wu X., Han J., Sun P. p38gamma regulates UV-induced checkpoint signaling and repair of UV-induced DNA damage. Protein Cell 2010, 1:573-583.
24. Kim M.J., Choi S.Y., Park I.C., Hwang S.G., Kim C., Choi Y.H., Kim H., Lee K.H., Lee S.J. Opposing roles of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase in the cellular response to ionizing radiation in human cervical cancer cells. Mol. Cancer Res. 2008, 6:1718-1731.
25. Paillas S., Boissiere F., Bibeau F., Denouel A., Mollevi C., Causse A., Denis V., Vezzio-Vie N., Marzi L., Cortijo C., Ait-Arsa I., Askari N., Pourquier P., Martineau P., Del Rio M., Gongora C. Targeting the p38 MAPK pathway inhibits irinotecan resistance in colon adenocarcinoma. Cancer Res. 2011, 71:1041-1049.
26. Wen J., Feng Y., Huang W., Chen H., Liao B., Rice L., Preti H.A., Kamble R.T., Zu Y., Ballon D.J., Chang C.C. Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition. Leuk. Res. 2010, 34:85-92.
27. Bulavin D.V., Saito S., Hollander M.C., Sakaguchi K., Anderson C.W., Appella E., Fornace A.J. Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J. 1999, 18:6845-6854.
28. Cuadrado A., Lafarga V., Cheung P.C., Dolado I., Llanos S., Cohen P., Nebreda A.R. A new p38 MAP kinase-regulated transcriptional coactivator that stimulates p53-dependent apoptosis. EMBO J. 2007, 26:2115-2126.
29. Han J., Sun P. The pathways to tumor suppression via route p38. Trends Biochem. Sci. 2007, 32:364-371.
30. Hsu S.C., Gavrilin M.A., Tsai M.H., Han J., Lai M.Z. p38 mitogen-activated protein kinase is involved in Fas ligand expression. J. Biol. Chem. 1999, 274:25769-25776.
31. Ghatan S., Larner S., Kinoshita Y., Hetman M., Patel L., Xia Z., Youle R.J., Morrison R.S. p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons. J. Cell. Biol. 2000, 150:335-347.
32. Zhuang S., Demirs J.T., Kochevar I.E. p38 mitogen-activated protein kinase mediates bid cleavage, mitochondrial dysfunction, and caspase-3 activation during apoptosis induced by singlet oxygen but not by hydrogen peroxide. J. Biol. Chem. 2000, 275:25939-25948.
33. Tanaka Y., Gavrielides M.V., Mitsuuchi Y., Fujii T., Kazanietz M.G. Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway. J. Biol. Chem. 2003, 278:33753-33762.
34. Tourian L., Zhao H., Srikant C.B. p38alpha, but not p38beta, inhibits the phosphorylation and presence of c-FLIPS in DISC to potentiate Fas-mediated caspase-8 activation and type I apoptotic signaling. J. Cell. Sci. 2004, 117:6459-6471.